SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Receptagen Ltd.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TERENCE DALY who wrote (146)7/31/1998 11:38:00 PM
From: Russell J. Gilbert  Read Replies (1) of 203
 
Terence,
Let's compare notes here for a while. Where do you see the stock price prior to the completion of the merger?
Post Merger consolidated price?

Personally, I would like to see RCG to go to around .10/share US before the merger is completed.
What are your thoughts?
When do you think the traders will jump back in and suppor the stock?

Side Note: I was one of the Principals in Ryan Pharm prior it being sold to RCG a few years ago. We owned the Co-Q10 patent for AIDS therapy. That was a jewel RCG acquired but sat on the back shelf due to one of their former idiot exec's with an ego the size of a watermelon and the common sense of an insect.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News